Skip to main content

Table 1 Distributions of participants’ characteristics by physician visit frequency for PD treatment using chi-square tests

From: Effects of physician visit frequency for Parkinson’s disease treatment on mortality, hospitalization, and costs: a retrospective cohort study

 

Higher frequency

Lower frequency

Total

P-value

Total

1045

1179

2224

 

Sex

   

0.31

 Male

430 (41.1%)

460 (39.0%)

890 (40.0%)

 

 Female

615 (58.9%)

719 (61.0%)

1334(60.0%)

 

Age

   

< 0.01

 75–79

291 (27.8%)

371 (31.5%)

662 (29.8%)

 

 80–84

348 (33.3%)

452 (38.3%)

800 (36.0%)

 

 85–89

284 (27.2%)

246 (20.9%)

530 (23.8%)

 

  ≥ 90

122 (11.7%)

110 (9.3%)

232 (10.4%)

 

Residential facility

   

< 0.01

 Home

734 (70.2%)

939 (79.6%)

1673 (75.2%)

 

 Retirement home

31 (3.0%)

54 (4.6%)

85 (3.8%)

 

 Long-term care facility

184 (17.6%)

184 (15.6%)

368 (16.5%)

 

 Health care institute

96 (9.2%)

2 (0.2%)

98(4.4%)

 

Long-term care level

   

0.04

 None

437 (41.8%)

506 (42.9%)

943 (42.4%)

 

 Requiring help

96 (9.2%)

147 (12.5%)

243 (10.9%)

 

 Long-term care level 1–2

248 (23.7%)

265 (22.5%)

513 (23.1%)

 

 Long-term care level 3–5

264 (25.3%)

261 (22.1%)

525 (23.6%)

 

Comorbidity

 Malignancy

259 (24.8%)

292 (24.8%)

551 (24.8%)

0.99

 Ischemic heart disease

459 (43.9%)

528 (44.8%)

987 (44.4%)

0.68

 Cerebrovascular disease

756 (72.3%)

808 (68.5%)

1564 (70.3%)

0.05

 Dyslipidemia

473 (45.3%)

610 (51.7%)

1083 (48.7%)

0.00

 Diabetes mellitus

443 (42.4%)

508 (43.1%)

951 (42.8%)

0.74

 Dementia

675 (64.6%)

735 (62.3%)

1410 (63.4%)

0.27

Mortality

589 (56.4%)

548 (46.5%)

1137 (51.1%)

< 0.01